Gemini Therapeutics, Inc.

NasdaqGM:GMTX Stock Report

Mkt Cap: US$58.5m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Gemini Therapeutics Dividend

What is Gemini Therapeutics's current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

Gemini Therapeutics Dividend Yield vs Market
How does GMTX dividend yield compare to the market?
SegmentDividend Yield
Company (GMTX)n/a
Market Bottom 25% (US)1.5%
Market Top 25% (US)4.3%
Industry Average (Biotechs)2.5%
Analyst forecast in 3 Years (GMTX)n/a

Notable Dividend: Unable to evaluate GMTX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate GMTX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

How stable has Gemini Therapeutics's dividend per share been in the past?
MonthDividend Per Share (annual)Avg. Yield (%)

Stable Dividend: Insufficient data to determine if GMTX's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if GMTX's dividend payments have been increasing.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as GMTX has not reported any payouts.

Discover strong dividend paying companies